Dementia is becoming one of the biggest threats to human health. However, there is no efficient therapeutic approach so far. Thus, traditional medicines, which have accumulated certain experience in the treatment of dementia, are attracting more and more attention. Indeed, many anti-dementia drugs or drug candidates have been derived from these medicines. In this article, the profile of anti-dementia agents contained in traditional Chinese medicine (TCM) is described. It is indicated that TCM is not only a rich source of acetylcholinesterase inhibitors, but also of great potential to derive other kinds of anti-dementia agents which are either directly associated with ameliorating dementia or have complementary effects. These agents have apparent implications for anti-dementia drug discovery, especially for finding multicomponent anti-dementia drugs.
Dementia, including Alzheimer's disease (AD) and vascular dementia, is becoming one of the most threatening diseases to humankind. It was estimated in 2005 that in the 14 World Health Organization (WHO) regions 24.3 million people had dementia, with 4 ~ 6 million new cases emerging every year [1] . However, due to the extremely complex pathogenesis of dementia, there is no efficient therapeutic approach so far. Thus, in recent years there has been an increasing interest in traditional medicines, for example traditional Chinese medicine (TCM), with the expectation of finding novel antidementia drugs from them [2] [3] [4] .
TCM, which has been used in China and surrounding countries for thousands of years, has accumulated certain experience in the treatment of dementia. More than one thousand TCM formulae have been created to combat this disease [5] . Therefore, TCM may have considerable potential to derive anti-dementia agents. In fact, the continuing efforts of medicinal chemists have led to the identification of a series of acetylcholinesterase (AChE) inhibitors from TCM (Figure 1 ) [6] [7] [8] . Some of them, such as huperzine A (HupA), are very promising anti-dementia drug candidates [9] . In addition, TCM also contains some AChE inhibitors initially identified from foreign herbs. For instance, from the TCM herb Lycoris radiata, galantamine can be extracted [3, 6] , which is a licensed AChE inhibitor for AD treatment in Europe and was derived from Galanthus nivalis, a herb traditionally used in Bulgaria and Turkey for neurological conditions [3] .
However, it should be pointed out that the anti-dementia potential of TCM components goes far beyond inhibiting AChE. For instance, (-)epigallocatechin gallate (EGCG), the representative component of green tea, has been revealed as a multipotent anti-dementia agent. Its activity includes reducing Aβ generation, inhibiting Aβ aggregation and inhibiting monoamine oxidase (MAO) [10] , which may be responsible for the benefits of green tea in preventing dementia [11] . Therefore, we think that it will be of interest and significance to provide a relatively comprehensive analysis of the potential of TCM as sources of anti-dementia agents. 
Profile of potential anti-dementia TCM agents
To get insight into the profile of TCM-contained anti-dementia agents, we first searched the activity and structure records of the traditional Chinese medicine database (TCMD), which documents 10,458 components extracted from 4636 herbs, animals and minerals [12] . Some compounds that are directly associated with anti-dementia were identified and are illustrated in Figure 2 . To find more antidementia agents from TCMD, we compared the structures of TCMD components with those recorded in the MDL Drug Data Report (MDDR), a wellknown database for drug candidates [13] . It was found that 161 TCMD members are also documented in MDDR, some of which are directly relevant to ameliorating dementia ( Figure 3 ). [5] . Nevertheless, the anti-dementia effects of these herbs are not necessarily completely determined by the displayed components, because dementia is coupled with many other diseases, such as hyperlipidemia, hypertension, diabetes mellitus and inflammation [14] , and thus, the components with hypolipidemic, antihypertensive, antidiabetic and anti-inflammatory potential may benefit the fight against dementia [15] . Besides, it has been revealed that anticonvulsant agents may also play a role in combating dementia [16] . To provide a deeper insight into the anti-dementia potential of TCM agents, we identified the hypolipidemic, antihypertensive, antidiabetic, anti-inflammatory and anticonvulsant components from some most frequently used anti-dementia TCM herbs [5] , through analyzing the activity and component annotations recorded in TCMD (Table 1 ).
In addition, by comparing the structures of TCMD components with those of MDDR members, more complementary anti-dementia components were revealed for these herbs (Table 1 ). It can be found that the most prevalent activity for these compounds is anti-inflammatory, followed by antihypertensive, hypolipidemic, antidiabetic (aldose reductase inhibitory and hypoglycemic) and anticonvulsant.
This finding is consistent with some modern medicinal observations. For instance, non-steroidal anti-inflammatory drugs, such as aspirin and indomethacin, have been implicated as potential therapeutic substances in AD [15d,e]. Certain antihypertensive drug classes, such as angiotensinconverting enzyme inhibitors, angiotensin II receptor blockers, diuretics, and calcium channel blockers, are likely to offer benefits for reducing dementia risk [15c]. In addition, relatively low prevalence of diagnosed AD and vascular dementia in hypercholesterolemic patients taking statins has been reported [15a,b] . Therefore, the complementary components contained in TCM herbs are highly possible to play an additive or even synergistic role with other agents in the treatment of dementia.
Since in history all nations have depended largely on natural products to combat all kinds of diseases, many folks other than the Chinese have also found some natural medicines with anti-dementia potential [3, 4, 6] . Considering the fact that a large number of herbal plants are distributed over the world, we speculate that the above-mentioned anti-dementia TCM herbs may have been recognized by other traditional medicinal systems, which stimulated our interest to perform a comparative analysis.
Through examining the usage history of the traditional Indian and European herbs, we found that foreign herbalists indeed have identified some antidementia herbs that are TCM counterparts. For example, Acorus tatarinowii and Salvia miltiorrhiza [3, 6, 17] , recorded in the ancient Chinese medicinal book Shen Nong Ben Cao Jing (compiled about 2000 years ago) [18] , are among the most frequently used anti-dementia TCM herbs [5] . In comparison, Acorus calamus is an Indian traditional herb with specific effects for rejuvenating the cerebral and central neural systems [4, 19] , and Salvia officinalis has had a reputation for being good for memory in England from the 16th century [3, 4] . In addition, Polygonatum sibiricum, which was annotated as a tonic and antiaging agent in the ancient Chinese medicinal book Ming Yi Bie Lu (edited between 220~450 AD) [18] , is now very frequently used in anti-dementia TCM formulae [5] . Interestingly, its Indian counterpart, Polygonatum verticillatum, was well known in the Ayurvedic system of medicine and highly valued for its rejuvenating, restorative and activating effects [6, 20] .
Therefore, it seems that some similar herbs have indeed been independently found to combat dementia by different medicinal systems, which not only provides more evidence to support the convergent evolution of medicinal systems [21, 22] , but also implies that these widely recognized herbs are highly possible sources from which to derive promising antidementia agents and thus should be given special attention.
Implications for anti-dementia drug discovery
The present analysis indicates that TCM has important implications for anti-dementia drug discovery. In particular, as TCM has accumulated plentiful anti-dementia formulae, it is of special significance for finding multicomponent antidementia drugs.
Since multiple factors are implicated in the pathogenesis of dementia, it has been widely accepted that the conventional single-target therapeutic strategy is not very efficient [23] . For instance, the clinical effects of AChE inhibitors are rather limited [24] . Therefore, it seems that an effective anti-dementia approach will have to rely on the multiple-target strategy, which can hit multiple targets implicated in dementia by either diverse components or even a single agent [25] . However, how to select appropriate components from the plentiful candidates to combine together remains a great challenge. Since TCM is best featured by 
Conclusions
The present analysis indicates that TCM is a rich source of anti-dementia agents. Some of them, such as AChE inhibitors, neuronal injury inhibitors, nootropic agents and those for curing cognition disorders, may have direct effects on dementia. Some others, for example, anti-inflammatory, antihypertensive, hypolipidemic, antidiabetic and anticonvulsant agents, may have complementary effects to dementia therapy. In anti-dementia TCM formulae, these agents are likely to play an additive or synergistic role. Therefore, TCM has important implications for anti-dementia drug discovery, especially for finding multicomponent anti-dementia drugs. Since only a tiny amount of TCM components have been identified and recorded in TCMD and only some TCMD members have activity annotations (in fact, even HupA has no annotation in this database), we think that the present analysis only reveals the tip of the iceberg for anti-dementia TCM components. It can be expected that with the rapid development in natural product chemistry, especially the progression of the Herbalome Project [28] , more anti-dementia compounds will be identified from TCM in the future.
